2008
DOI: 10.1016/j.surg.2008.04.012
|View full text |Cite
|
Sign up to set email alerts
|

The preventive effect of Met-RANTES on postoperative intraperitoneal adhesion formation in the rat model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 54 publications
0
7
0
Order By: Relevance
“…Neither one of the present authors (MD) nor others (27)(28)(29)(30) have been able to identify molecular biologic evidence of an impact of modified hyaluronic acid and carboxymethylcellulose on mRNA expression of tissue plasminogen activator (28), collagen I, transforming growth factor beta (28), matrix metalloproteinase I (28), tissue plasminogen activator activity (28), vascular endothelial growth factor expression (29), or polymorphonuclear neutrophil (PMN) phagocytosis. Similarly, there does not appear to be a change in the rate of PMN apoptosis/necrosis, production of cytokines (tumor necrosis factor-alpha, interleukin-1a, interleukin-6, interleukin-8, interleukin-1 receptor antagonist), or PMN elastase in response to the use of this product (30).…”
Section: Discussionmentioning
confidence: 93%
“…Neither one of the present authors (MD) nor others (27)(28)(29)(30) have been able to identify molecular biologic evidence of an impact of modified hyaluronic acid and carboxymethylcellulose on mRNA expression of tissue plasminogen activator (28), collagen I, transforming growth factor beta (28), matrix metalloproteinase I (28), tissue plasminogen activator activity (28), vascular endothelial growth factor expression (29), or polymorphonuclear neutrophil (PMN) phagocytosis. Similarly, there does not appear to be a change in the rate of PMN apoptosis/necrosis, production of cytokines (tumor necrosis factor-alpha, interleukin-1a, interleukin-6, interleukin-8, interleukin-1 receptor antagonist), or PMN elastase in response to the use of this product (30).…”
Section: Discussionmentioning
confidence: 93%
“…The intra-abdominal administration of antiadhesive barriers, such as a bioresorbable membrane consisting of sodium hyaluronate, polyethylene glycol, fibrin sealant, oxidized regenerated cellulose, expanded polytetrafluoroethylene, and carboxymethylcellulose, may reduce postoperative adhesions, as demonstrated by some animal models and clinical studies [1, 46]. Some of these agents have been shown to reduce the number and quality of adhesions, but none are universally effective and their modes of action are poorly understood [8, 17]. …”
Section: Discussionmentioning
confidence: 99%
“…Prevention of fibrin formation with pharmacological agents, such as corticosteroids, heparin or tissue plasminogen activator, sodium hyaluronate, urokinase, application of anti-adhesive film modified chitosan (Murata et al, 2006;Singer et al, 1996b); 3. Reduction of the contact between organs and intraabdominal contents by using biodegradable barriers such as sodium hyaluronate (SHA), seprafilm, seprafilm antiadhesion film (Akyildiz et al, 2008); 4. Use of various biologically active substances such as intraoperative use of biological polysaccharide flushing liquid.…”
Section: Introductionmentioning
confidence: 99%
“…Some of them are only effective in the short term. Some have no impact on inflammation activity, while others have severe detrimental impacts (Akyildiz et al, 2008).…”
Section: Introductionmentioning
confidence: 99%